May 25, 2011 (Honolulu, Hawaii) — Switching from the atypical antipsychotics olanzapine, quetiapine, or risperidone to the atypical antipsychotic aripiprazole may reduce metabolic risk in patients ...
New University of Pittsburgh research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications. The study, including experiments in ...
Hosted on MSN
Finding balance with antipsychotic treatments
Which works best: Network meta-analyses show lurasidone, quetiapine, olanzapine, and cariprazine outperform placebo for bipolar depression, with lurasidone showing strong response rates. Side effect ...
Donald Goff, Jeffrey Lieberman, and colleagues recently published a review article entitled “The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia” in the American ...
BOSTON, Oct 5 (Reuters) - Eli Lilly & Co said on Friday its antipsychotic Zyprexa was more likely than rival treatments to raise blood glucose levels, a condition that can lead to diabetes, and has ...
Second-generation antipsychotics (SGAs) are essential for managing serious mental health conditions, but they can significantly increase risks for metabolic syndrome, diabetes, and heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results